Safety vs Speed in the Race for a Vaccine

More people are using fertility treatments to have kids later. But how much time can science really buy? Sanjay talks with reproductive endocrinologist Dr. Lucky Sekhon about what science can — and can’t — promise. Jennifer Lai and Leying Tang produced this episode. Video product ...  Show more

Antidepressants are some of the most prescribed drugs in the US, but they may not be getting proper scrutiny. Dr. Sanjay Gupta talks to psychopharmacologist Dr. Joseph Goldberg about what to consider when stopping or starting one. Madeleine Thompson & Sofia Sanchez produced this ...  Show more

Scientists are racing to develop a safe, effective, vaccine for COVID-19 – but will people be willing to take it when it's available? We already have a flu vaccine, but less than half of Americans get it each year. Gretchen Chapman, PhD, a cognitive psychologist who studies healt ...  Show more

Dr. Francis Collins talks with health correspondent Selena Simmons-Duffin about Americans' overall health, how tribalism in American culture has fueled vaccine hesitancy, and advises his successor on how to persevere on research of politically charged topics — like guns and obesi ...  Show more

The race for a COVID-19 vaccine entered a new phase recently. Four different vaccine candidates, developed by Moderna, Pfizer, BionTech and Johnson & Johnson, entered final-stage trials, with two others close behind. But we won’t know exactly how these four vaccines work for mont ...  Show more

Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more ...